{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:57Z","timestamp":1781636097275,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) remains one of the most commonly diagnosed malignancies worldwide and is associated with high recurrence and poor survival outcomes, particularly in its advanced stages. Zi-Shen-Gu-Sui Decoction (ZSGSD), a traditional Chinese medicinal formula, has been clinically applied in CRC treatment and postoperative rehabilitation; however, its pharmacological mechanisms are not yet fully elucidated. This study aimed to explore the anti-CRC efficacy and molecular mechanisms of ZSGSD, with particular attention to the PI3K\/AKT\/mTOR signaling axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>UPLC-Q-Orbitrap HRMS was utilized to characterize the chemical profile of ZSGSD. Network pharmacology was employed to identify key signaling pathways and bioactive compounds, and molecular docking was conducted to predict potential interactions between major constituents and PI3K\/AKT\/mTOR proteins. A xenograft mouse model of CRC was established to evaluate tumor suppression. Histological staining was used to assess apoptosis, and the expression of PI3K, AKT, and mTOR was quantified via RT-qPCR, Western blotting, and immunofluorescence assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Sixty compounds were identified in ZSGSD, with flavonoids comprising approximately 50%. Network analysis suggested potential involvement of the PI3K\/AKT\/mTOR pathway, and docking results indicated favorable predicted binding between key flavonoids (including Genistein, Apigenin, and Naringenin) and proteins within this pathway. In vivo, ZSGSD treatment suppressed tumor growth in a dose-responsive fashion, with tumor inhibition rates ranging from 30.83% to 75.23% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Histological evaluations revealed reduced nuclear-to-cytoplasmic ratios and enhanced apoptotic activity, as confirmed by TUNEL staining (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Molecular analyses showed a dose-related reduction in PI3K, AKT, and mTOR expression at the transcript and protein levels, indicating that this pathway may be modulated during ZSGSD treatment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ZSGSD demonstrates notable tumor-suppressive and pro-apoptotic effects in a CRC xenograft model. These outcomes appear to be associated with modulation of the PI3K\/AKT\/mTOR signaling pathway, although further functional studies are required to confirm pathway specificity and clarify causal mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00636-3","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T03:44:27Z","timestamp":1771213467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ZSGSD inhibits colorectal cancer via PI3K\/AKT\/mTOR pathway: pharmacological and experimental evidence"],"prefix":"10.1186","volume":"163","author":[{"given":"Ting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingquan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"7","key":"636_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in china: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783\u201391.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"636_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"636_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"636_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mam.2019.01.002","volume":"69","author":"AJ Cornish","year":"2019","unstructured":"Cornish AJ, Tomlinson IPM, Houlston RS. Mendelian randomisation: A powerful and inexpensive method for identifying and excluding non-genetic risk factors for colorectal cancer. Mol Aspects Med. 2019;69:41\u20137.","journal-title":"Mol Aspects Med"},{"issue":"23","key":"636_CR5","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1002\/cncr.32163","volume":"125","author":"S Piawah","year":"2019","unstructured":"Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019;125(23):4139\u201347.","journal-title":"Cancer"},{"issue":"8","key":"636_CR6","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386\u2013422.","journal-title":"Ann Oncol"},{"issue":"1","key":"636_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12929-023-00930-6","volume":"30","author":"P Li","year":"2023","unstructured":"Li P, Zhou D, Chen D, Cheng Y, Chen Y, Lin Z, et al. Tumor-secreted IFI35 promotes proliferation and cytotoxic activity of CD8(+) T cells through PI3K\/AKT\/mTOR signaling pathway in colorectal cancer. J Biomed Sci. 2023;30(1):47.","journal-title":"J Biomed Sci"},{"key":"636_CR8","doi-asserted-by":"publisher","first-page":"819128","DOI":"10.3389\/fonc.2022.819128","volume":"12","author":"Y Peng","year":"2022","unstructured":"Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway? Front Oncol. 2022;12:819128.","journal-title":"Front Oncol"},{"issue":"12","key":"636_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/1440-1681.12493","volume":"42","author":"J Chen","year":"2015","unstructured":"Chen J, Shao R, Li F, Monteiro M, Liu JP, Xu ZP, et al. PI3K\/Akt\/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells. Clin Exp Pharmacol Physiol. 2015;42(12):1317\u201326.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"636_CR10","doi-asserted-by":"publisher","first-page":"2824984","DOI":"10.1155\/2020\/2824984","volume":"2020","author":"ZS Hong","year":"2020","unstructured":"Hong ZS, Zhuang HB, Qiu CZ, Shi ZS, Wang CX, Chen ZC, et al. Tenacissoside H induces apoptosis and inhibits migration of colon cancer cells by downregulating expression of GOLPH3 gene. Evid Based Complement Alternat Med. 2020;2020:2824984.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"636_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3892\/ijo.2020.5151","volume":"58","author":"J Wang","year":"2021","unstructured":"Wang J, Liang D, Zhang XP, He CF, Cao L, Zhang SQ, et al. Novel PI3K\/Akt\/mTOR signaling inhibitor, W922, prevents colorectal cancer growth via the regulation of autophagy. Int J Oncol. 2021;58(1):70\u201382.","journal-title":"Int J Oncol"},{"issue":"1","key":"636_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12885-019-5824-9","volume":"19","author":"J Deng","year":"2019","unstructured":"Deng J, Bai X, Feng X, Ni J, Beretov J, Graham P, et al. Inhibition of PI3K\/Akt\/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. BMC Cancer. 2019;19(1):618.","journal-title":"BMC Cancer"},{"issue":"39","key":"636_CR13","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.2174\/0929867327666201109122025","volume":"28","author":"I Badar Ul","year":"2021","unstructured":"Badar Ul I, Khan MS, Husain FM, Rehman MT, Zughaibi TA, Abuzenadah AM, et al. mTOR targeted cancer chemoprevention by flavonoids. Curr Med Chem. 2021;28(39):8068\u201382.","journal-title":"Curr Med Chem"},{"key":"636_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394.","journal-title":"Semin Cancer Biol"},{"key":"636_CR15","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.2147\/CMAR.S250661","volume":"12","author":"W Xu","year":"2020","unstructured":"Xu W, Yu M, Qin J, Luo Y, Zhong M. LACTB regulates PIK3R3 to promote autophagy and inhibit EMT and proliferation through the PI3K\/AKT\/mTOR signaling pathway in colorectal cancer. Cancer Manag Res. 2020;12:5181\u2013200.","journal-title":"Cancer Manag Res"},{"key":"636_CR16","doi-asserted-by":"publisher","first-page":"1140325","DOI":"10.3389\/fmolb.2023.1140325","volume":"10","author":"T Li","year":"2023","unstructured":"Li T, Han L, Ma S, Lin W, Ba X, Yan J, et al. Interaction of gut microbiota with the tumor microenvironment: A new strategy for antitumor treatment and traditional Chinese medicine in colorectal cancer. Front Mol Biosci. 2023;10:1140325.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"636_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12906-017-2006-7","volume":"17","author":"J Pan","year":"2017","unstructured":"Pan J, Xu Y, Song H, Zhou X, Yao Z, Ji G. Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt\/\u03b2-catenin signaling in colorectal cancer cells. BMC Complement Altern Med. 2017;17(1):506.","journal-title":"BMC Complement Altern Med"},{"issue":"3","key":"636_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1142\/S0192415X20500354","volume":"48","author":"J Wang","year":"2020","unstructured":"Wang J, Cai H, Liu Q, Xia Y, Xing L, Zuo Q, et al. Cinobufacini inhibits colon cancer invasion and metastasis via suppressing Wnt\/\u03b2-Catenin signaling pathway and EMT. Am J Chin Med. 2020;48(3):703\u201318.","journal-title":"Am J Chin Med"},{"issue":"6","key":"636_CR19","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1053\/j.gastro.2023.08.052","volume":"165","author":"H Gou","year":"2023","unstructured":"Gou H, Su H, Liu D, Wong CC, Shang H, Fang Y, et al. Traditional medicine Pien tze Huang suppresses colorectal tumorigenesis through restoring gut microbiota and metabolites. Gastroenterology. 2023;165(6):1404\u201319.","journal-title":"Gastroenterology"},{"issue":"1","key":"636_CR20","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1186\/s12885-024-12898-z","volume":"24","author":"W Deng","year":"2024","unstructured":"Deng W, Xiong X, Lu M, Huang S, Luo Y, Wang Y, et al. Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites. BMC Cancer. 2024;24(1):1141.","journal-title":"BMC Cancer"},{"key":"636_CR21","doi-asserted-by":"crossref","unstructured":"Abmad I, Hogue M, Alam SSM, Zughaibi TA, Tabrez S. Curcumin and Plumbagin synergiutically target the PI3K\/Akt mTOR pathway: A prospective role in cancer treatment. Int J Mol Sci. 2023;24(7):6651.","DOI":"10.3390\/ijms24076651"},{"key":"636_CR22","unstructured":"Wu T. Short-term clinical observation of Zishen Gusui Decoction combined with chemotherapy in postoperative patients with mid-stage colorectal cancer [Master\u2019s thesis]. Guangzhou: Guangzhou University of Chinese Medicine; 2019."},{"issue":"Pt 1","key":"636_CR23","doi-asserted-by":"publisher","first-page":"118840","DOI":"10.1016\/j.jep.2024.118840","volume":"337","author":"Y Chen","year":"2025","unstructured":"Chen Y, Gao T, Bai J, Yu L, Liu Y, Li Y, et al. Ge-Zhi-Jie-Jiu Decoction alleviates alcoholic liver disease through multiple signaling pathways. J Ethnopharmacol. 2025;337(Pt 1):118840.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"636_CR24","first-page":"131","volume":"45","author":"G Zhu","year":"2020","unstructured":"Zhu G, Cheng Z, Huang Y, Zheng W, Yang S, Lin C, et al. MyD88 mediates colorectal cancer cell proliferation, migration and invasion via NF\u2013\u03baB\/AP\u20131 signaling pathway. Int J Mol Med. 2020;45(1):131\u201340.","journal-title":"Int J Mol Med"},{"issue":"3\u20134","key":"636_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41434-020-0176-2","volume":"29","author":"ZY Chen","year":"2022","unstructured":"Chen ZY, Wang XY, Yang YM, Wu MH, Yang L, Jiang DT, et al. LncRNA SNHG16 promotes colorectal cancer cell proliferation, migration, and epithelial-mesenchymal transition through miR-124-3p\/MCP-1. Gene Ther. 2022;29(3\u20134):193\u2013205.","journal-title":"Gene Ther"},{"issue":"5","key":"636_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00432-024-05763-w","volume":"150","author":"L Liu","year":"2024","unstructured":"Liu L, Zhao M, Lang X, Jia S, Kang X, Liu Y, et al. Modified Lichong Decoction intervenes in colorectal cancer by modulating the intestinal flora and the Wnt\/\u03b2-catenin signaling pathway. J Cancer Res Clin Oncol. 2024;150(5):234.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"636_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"9654","key":"636_CR28","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(08)61354-9","volume":"372","author":"JL Tang","year":"2008","unstructured":"Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet. 2008;372(9654):1938\u201340.","journal-title":"Lancet"},{"issue":"10","key":"636_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.2174\/138620710793360329","volume":"13","author":"P Zhou","year":"2010","unstructured":"Zhou P. Traditional Chinese medicine. Comb Chem High Throughput Screen. 2010;13(10):836.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"5","key":"636_CR30","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/cam4.2108","volume":"8","author":"Y Xiang","year":"2019","unstructured":"Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. Traditional Chinese medicine as a cancer treatment: modern perspectives of ancient but advanced science. Cancer Med. 2019;8(5):1958\u201375.","journal-title":"Cancer Med"},{"key":"636_CR31","doi-asserted-by":"publisher","first-page":"155385","DOI":"10.1016\/j.phymed.2024.155385","volume":"128","author":"K Cai","year":"2024","unstructured":"Cai K, Cao XY, Chen F, Zhu Y, Sun DD, Cheng HB, et al. Xianlian Jiedu Decoction alleviates colorectal cancer by regulating metabolic profiles, intestinal microbiota and metabolites. Phytomedicine. 2024;128:155385.","journal-title":"Phytomedicine"},{"key":"636_CR32","doi-asserted-by":"publisher","first-page":"117995","DOI":"10.1016\/j.jep.2024.117995","volume":"326","author":"X Wei","year":"2024","unstructured":"Wei X, Liang J, Liu J, Dai Y, Leng X, Cheng Y, et al. Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota. J Ethnopharmacol. 2024;326:117995.","journal-title":"J Ethnopharmacol"},{"key":"636_CR33","doi-asserted-by":"publisher","first-page":"153966","DOI":"10.1016\/j.phymed.2022.153966","volume":"98","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Feng Y, Cen R, Hou X, Yu H, Sun J, et al. San-Wu-Huang-Qin Decoction attenuates tumorigenesis and mucosal barrier impairment in the AOM\/DSS model by targeting gut Microbiome. Phytomedicine. 2022;98:153966.","journal-title":"Phytomedicine"},{"issue":"1","key":"636_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12964-020-00596-9","volume":"18","author":"H Sui","year":"2020","unstructured":"Sui H, Zhang L, Gu K, Chai N, Ji Q, Zhou L, et al. YYFZBJS ameliorates colorectal cancer progression in Apc(Min\/+) mice by remodeling gut microbiota and inhibiting regulatory T-cell generation. Cell Commun Signal. 2020;18(1):113.","journal-title":"Cell Commun Signal"},{"key":"636_CR35","doi-asserted-by":"publisher","first-page":"892790","DOI":"10.3389\/fphar.2022.892790","volume":"13","author":"S Yuan","year":"2022","unstructured":"Yuan S, Li Y, Li J, Xue JC, Wang Q, Hou XT, et al. Traditional Chinese medicine and natural products: potential approaches for inflammatory bowel disease. Front Pharmacol. 2022;13:892790.","journal-title":"Front Pharmacol"},{"key":"636_CR36","doi-asserted-by":"crossref","unstructured":"Shang L, Wang Y, Li J, Zhou F, Xiao K, Liu Y et al. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network Pharmacology and experimental validation. J Ethnopharmacol. 2023;302(Pt A):115876.","DOI":"10.1016\/j.jep.2022.115876"},{"issue":"Pt 3","key":"636_CR37","doi-asserted-by":"publisher","first-page":"117323","DOI":"10.1016\/j.jep.2023.117323","volume":"319","author":"Y Wu","year":"2024","unstructured":"Wu Y, Fang Y, Li Y, Au R, Cheng C, Li W, et al. A network Pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK\/p38 MAPK signaling pathway. J Ethnopharmacol. 2024;319(Pt 3):117323.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"636_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41419-019-1638-6","volume":"10","author":"J Lv","year":"2019","unstructured":"Lv J, Jia Y, Li J, Kuai W, Li Y, Guo F, et al. Gegen Qinlian Decoction enhances the effect of PD-1 Blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment. Cell Death Dis. 2019;10(6):415.","journal-title":"Cell Death Dis"},{"key":"636_CR39","doi-asserted-by":"publisher","first-page":"112241","DOI":"10.1016\/j.biopha.2021.112241","volume":"143","author":"J Fern\u00e1ndez","year":"2021","unstructured":"Fern\u00e1ndez J, Silv\u00e1n B, Entrialgo-Cadierno R, Villar CJ, Capasso R, Uranga JA, et al. Antiproliferative and palliative activity of flavonoids in colorectal cancer. Biomed Pharmacother. 2021;143:112241.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"636_CR40","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1039\/C5FO00374A","volume":"6","author":"J Chen","year":"2015","unstructured":"Chen J, Zhao X, Li X, Wu Y. Calycosin induces apoptosis by the regulation of ER\u03b2\/miR-17 signaling pathway in human colorectal cancer cells. Food Funct. 2015;6(9):3091\u20137.","journal-title":"Food Funct"},{"issue":"5","key":"636_CR41","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1159\/000374013","volume":"35","author":"J Qin","year":"2015","unstructured":"Qin J, Chen JX, Zhu Z, Teng JA. Genistein inhibits human colorectal cancer growth and suppresses miR-95, Akt and SGK1. Cell Physiol Biochem. 2015;35(5):2069\u201377.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"636_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.31083\/j.fbl2802037","volume":"28","author":"J Zhong","year":"2023","unstructured":"Zhong J, Ding S, Zhang X, Di W, Wang X, Zhang H, et al. To investigate the occurrence and development of colorectal cancer based on the PI3K\/AKT\/mTOR signaling pathway. Front Biosci (Landmark Ed). 2023;28(2):37.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"636_CR43","doi-asserted-by":"crossref","unstructured":"Salehi B, Venditti A, Sharifi- Rad M, Krgiel D, Sharifi- Rad J, Duazzo A, et al. The therapeutic potential of apigenin. Int J Mol Sci. 2019;20(6):1305","DOI":"10.3390\/ijms20061305"},{"issue":"8","key":"636_CR44","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/ptr.6647","volume":"34","author":"M Imran","year":"2020","unstructured":"Imran M, Aslam Gondal T, Atif M, Shahbaz M, Batool Qaisarani T, Hanif Mughal M, et al. Apigenin as an anticancer agent. Phytother Res. 2020;34(8):1812\u201328.","journal-title":"Phytother Res"},{"issue":"11","key":"636_CR45","doi-asserted-by":"publisher","first-page":"6789","DOI":"10.1002\/fsn3.3645","volume":"11","author":"S Daneshvar","year":"2023","unstructured":"Daneshvar S, Zamanian MY, Ivraghi MS, Golmohammadi M, Modanloo M, Kamiab Z, et al. A comprehensive view on the apigenin impact on colorectal cancer: focusing on cellular and molecular mechanisms. Food Sci Nutr. 2023;11(11):6789\u2013801.","journal-title":"Food Sci Nutr"},{"key":"636_CR46","doi-asserted-by":"crossref","unstructured":"Rahmani AH, Alsahli MA, Almatroudi A, Almogbel MA, Khan AA, Anwar S et al. The potential role of apigenin in cancer prevention and treatment. Molecules. 2022;27(18).","DOI":"10.3390\/molecules27186051"},{"issue":"1","key":"636_CR47","doi-asserted-by":"publisher","first-page":"tfae011","DOI":"10.1093\/toxres\/tfae011","volume":"13","author":"C Zhang","year":"2024","unstructured":"Zhang C, Liao Y, Li T, Zhong H, Shan L, Yu P, et al. Apigenin promotes apoptosis of 4T1 cells through PI3K\/AKT\/Nrf2 pathway and improves tumor immune microenvironment in vivo. Toxicol Res (Camb). 2024;13(1):tfae011.","journal-title":"Toxicol Res (Camb)"},{"issue":"5","key":"636_CR48","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/iub.2456","volume":"73","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang W, Chen F, Lu Z. Combined effect of Chrysin and apigenin on inhibiting the development and progression of colorectal cancer by suppressing the activity of P38-MAPK\/AKT pathway. IUBMB Life. 2021;73(5):774\u201383.","journal-title":"IUBMB Life"},{"issue":"20","key":"636_CR49","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.7150\/jca.95775","volume":"15","author":"L Liu","year":"2024","unstructured":"Liu L, Qiu Y, Peng Z, Yu Z, Lu H, Xie R, et al. Genistein induces ferroptosis in colorectal cancer cells via FoxO3\/SLC7A11\/GPX4 signaling pathway. J Cancer. 2024;15(20):6741\u201353.","journal-title":"J Cancer"},{"issue":"1","key":"636_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3109\/13880209.2015.1014921","volume":"54","author":"J Qin","year":"2016","unstructured":"Qin J, Teng J, Zhu Z, Chen J, Huang WJ. Genistein induces activation of the mitochondrial apoptosis pathway by inhibiting phosphorylation of Akt in colorectal cancer cells. Pharm Biol. 2016;54(1):74\u20139.","journal-title":"Pharm Biol"},{"issue":"4","key":"636_CR51","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.3892\/mmr.2017.6260","volume":"15","author":"J Zhang","year":"2017","unstructured":"Zhang J, Su H, Li Q, Li J, Zhao Q. Genistein decreases A549 cell viability via Inhibition of the PI3K\/AKT\/HIF\u20131\u03b1\/VEGF and NF\u2013\u03baB\/COX\u20132 signaling pathways. Mol Med Rep. 2017;15(4):2296\u2013302.","journal-title":"Mol Med Rep"},{"key":"636_CR52","doi-asserted-by":"publisher","first-page":"e16159","DOI":"10.7717\/peerj.16159","volume":"11","author":"D Dzhalilova","year":"2023","unstructured":"Dzhalilova D, Zolotova N, Fokichev N, Makarova O. Murine models of colorectal cancer: the azoxymethane (AOM)\/dextran sulfate sodium (DSS) model of colitis-associated cancer. PeerJ. 2023;11:e16159.","journal-title":"PeerJ"},{"key":"636_CR53","doi-asserted-by":"publisher","first-page":"216704","DOI":"10.1016\/j.canlet.2024.216704","volume":"587","author":"R Pothuraju","year":"2024","unstructured":"Pothuraju R, Khan I, Jain M, Bouvet M, Malafa M, Roy HK, et al. Colorectal cancer murine models: initiation to metastasis. Cancer Lett. 2024;587:216704.","journal-title":"Cancer Lett"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00636-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00636-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00636-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:17:51Z","timestamp":1781633871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00636-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00636-3","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the ARRIVE guidelines and the principles of Replacement, Reduction, and Refinement (3Rs). The study protocol was reviewed and approved by the Institutional Animal Care and Use Committee of Hainan Provincial Hospital of Traditional Chinese Medicine (Approval No. IACUC-HPHCM-2307008).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}